PCN35 - Survival after locoregional recurrence or second primary breast cancer: Impact of the disease-free interval

    Research output: Contribution to journalArticleAcademicpeer-review

    14 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)A620-
    JournalValue in health
    Volume17
    Issue number7
    DOIs
    Publication statusPublished - 8 Nov 2014
    EventISPOR 17th Annual European Congress 2014: New challenges for improving European health care - Amsterdam RAI, Amsterdam, Netherlands
    Duration: 8 Nov 201412 Nov 2014

    Keywords

    • IR-93188
    • METIS-307154

    Cite this

    @article{157658f91dd742a391dec8155ccbe17d,
    title = "PCN35 - Survival after locoregional recurrence or second primary breast cancer: Impact of the disease-free interval",
    keywords = "IR-93188, METIS-307154",
    author = "Annemieke Witteveen and A.B.G. Kwast and G. Sonke and IJzerman, {Maarten Joost} and Sabine Siesling",
    year = "2014",
    month = "11",
    day = "8",
    doi = "10.1016/j.jval.2014.08.2193",
    language = "English",
    volume = "17",
    pages = "A620--",
    journal = "Value in health",
    issn = "1098-3015",
    publisher = "Elsevier",
    number = "7",

    }

    PCN35 - Survival after locoregional recurrence or second primary breast cancer: Impact of the disease-free interval. / Witteveen, Annemieke; Kwast, A.B.G.; Sonke, G.; IJzerman, Maarten Joost; Siesling, Sabine.

    In: Value in health, Vol. 17, No. 7, 08.11.2014, p. A620-.

    Research output: Contribution to journalArticleAcademicpeer-review

    TY - JOUR

    T1 - PCN35 - Survival after locoregional recurrence or second primary breast cancer: Impact of the disease-free interval

    AU - Witteveen, Annemieke

    AU - Kwast, A.B.G.

    AU - Sonke, G.

    AU - IJzerman, Maarten Joost

    AU - Siesling, Sabine

    PY - 2014/11/8

    Y1 - 2014/11/8

    KW - IR-93188

    KW - METIS-307154

    U2 - 10.1016/j.jval.2014.08.2193

    DO - 10.1016/j.jval.2014.08.2193

    M3 - Article

    VL - 17

    SP - A620-

    JO - Value in health

    JF - Value in health

    SN - 1098-3015

    IS - 7

    ER -